Health Canada and FDA aware some metformin diabetes medicines in other countries were reported to have low levels of NDMA, a cancer-causing chemical that prompted a recall of a commonly used heartburn medication this year.
Health Canada and FDA aware some metformin diabetes medicines in other countries were reported to have low levels of NDMA, a cancer-causing chemical that prompted a recall of a commonly used heartburn medication this year.